Please assess the completion status of the following clinical trial:

Trial Title: Pilot Phase 2 Study Whole Brain Radiation Therapy With Simultaneous Integrated Boost for Patients With Brain Metastases

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria~1. Age ≥ 18 at time of consent.~2. Ability to provide written informed consent and HIPAA authorization.~3. Pathological diagnosis of any solid tumor histology (from any site in the body).~4. Pathological or clinical (i.e., by imaging) diagnosis of brain metastatic tumor lesions.~5. Total volume of lesions ≤ 30 cm3.~6. Maximum volume of largest lesion ≤ 5 cm3.~   a. This volume limit would be equivalent to a largest diameter of about 2.1 cm, assuming a perfect sphere.~7. Not a candidate for or eligible for but refused Gamma Knife radiosurgery.~Exclusion Criteria~1. Previous radiation to the brain, including WBRT or brain radiosurgery.~2. Life expectancy \< 6 months (as estimated per current ds-GPA).~3. For histologies not included in the ds-GPA publications or otherwise noted online at brainmetgpa.com, the PI will use either published or validated data, or the PI's best clinical judgment to determine the patient's expected survival.~4. Inability to comply with treatment per investigator discretion.~5. Inability to complete neurocognitive assessments per investigator discretion.~Of note, tumor lesion number is not an inclusion or exclusion criteria as we are using volume-based criteria instead.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cohort A (Type: EXPERIMENTAL): Standard PCI dose
- Cohort B (Type: EXPERIMENTAL): Low PCI dose

Based on this trial design, predict the completion outcome and termination type (if applicable).